# Sensor-augmented Pump Versus Multiple Daily Injections With Degludec as Basal Insulin for Insulin Therapy in Type 1 Diabetes

> **NCT03557892** · NA · COMPLETED · sponsor: **Azienda Ospedaliero-Universitaria Careggi** · enrollment: 28 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** CGM+CSII
- **DEVICE:** MDI with degludec

## Key facts

- **NCT ID:** NCT03557892
- **Lead sponsor:** Azienda Ospedaliero-Universitaria Careggi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-01
- **Primary completion:** 2019-12-20
- **Final completion:** 2020-01-02
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03557892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03557892, "Sensor-augmented Pump Versus Multiple Daily Injections With Degludec as Basal Insulin for Insulin Therapy in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03557892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*